Ultherapy® Named “Best Skin Tightening Device” by The Aesthetic Guide
Merz announced today Ultherapy® has been named the “Best Skin Tightening Device” by THE Aesthetic Guide, a leading aesthetic industry publication. Ultherapy® is the only FDA- cleared, non-invasive procedure that lifts and tightens the neck, chin and brow, and improves lines and wrinkles on the chest.
THE Aesthetic Industry Awards acknowledge leaders who have developed innovative, cutting edge technologies, techniques and best practices that have been pushing the industry forward. A distinguished panel of expert judges selected top products and services in a broad range of categories.
“My patients are always looking for trusted treatments that will help them look fresher and Ultherapy continues to be a treatment I recommend because it has no downtime and delivers visible results,” said Dr. Patricia Wexler, a New York City-based cosmetic dermatologist who has treated brand ambassador Christie Brinkley with Ultherapy. “The targeted ultrasound technology makes Ultherapy a revolutionary device that allows me to customize treatments to meet the needs of my patients.”
Ultherapy® is the only cosmetic procedure to use ultrasound imaging, which allows physicians to see the layers of tissue targeted during the treatment to ensure the energy is deposited where it will be most beneficial. The unique technology is supported by more than 50 clinical studies, more than 60 published, peer-reviewed papers and over 100 patents.
“This award is a true testament to Ultherapy’s innovation and proven results,” said Bob Rhatigan, CEO of Merz North America. “Ultherapy is trusted by physicians around the world and continues to be recognized in the industry for its one-of-a-kind clinically-proven technology. We are proud to have celebrated the milestone of one million treatments with Ultherapy earlier this year and look forward to the next million.”
For more information about Ultherapy®, visit: http://www.ultherapy.com.
As the first and only treatment FDA-cleared to non-invasively lift the eyebrow, neck and chin, and to improve lines and wrinkles on the décolletage, Ultherapy® is the only cosmetic procedure to use ultrasound imaging to target the skin’s foundational layer to lift and tighten naturally, without surgery or downtime. The most common side effects reported in clinical trials were redness, swelling, pain and transient nerve effects.
Reported adverse events from post-marketing surveillance are available in the Instructions for Use (IFU). Please see the IFU for product and safety information, including a full list of these events at www.Ultherapy.com/IFU.
About Merz North America, Inc.
Merz North America, Inc. is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients’ health and quality of life by delivering therapies that bring about real progress. Merz North America is a privately-held company based in Raleigh, North Carolina. To learn more about Merz North America, Inc., please visit www.merzusa.com.
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.
12.04.20172 [ 0 KB ]
Merz North America